Trial Profile
The Diabetes Virus Detection and Intervention Trial (DiViDIntervention)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Dec 2023
Price :
$35
*
At a glance
- Drugs Pleconaril (Primary) ; Ribavirin (Primary)
- Indications Viral infections
- Focus Pharmacodynamics
- Acronyms DiViDIntervention
- 18 Dec 2023 Sweden is the planned location as per European Clinical Trials Database record.
- 01 Nov 2023 Results published in the Nature Medicine
- 06 Oct 2023 Primary endpoint (The primary endpoint is change in mean residual insulin secretion measured by Mixed Meal Tolerance Test (MMTT) stimulated C-peptide two-hour area under the curve profile from visit 1 to 12 months after initiation of study treatment.) has been met according to results presented at the 59th Annual Meeting of the European Association for the Study of Diabetes.